BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 34109210)

  • 1. Identifying Dendritic Cell-Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis.
    Huang C; Jiang X; Huang Y; Zhao L; Li P; Liu F
    Front Mol Biosci; 2021; 8():636991. PubMed ID: 34109210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
    Dai K; Liu C; Guan G; Cai J; Wu L
    BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
    Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X
    BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
    Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
    Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
    Lin Z; Xu Q; Miao D; Yu F
    Front Oncol; 2021; 11():644416. PubMed ID: 33828988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L; Wang L; He P
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [No Abstract]   [Full Text] [Related]  

  • 8. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Li W; Lu J; Ma Z; Zhao J; Liu J
    Front Genet; 2019; 10():1323. PubMed ID: 32010188
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis.
    Zhu W; Ru L; Ma Z
    Front Oncol; 2021; 11():626654. PubMed ID: 33777771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and validation of an angiogenesis-related scoring model to predict prognosis, tumor immune microenvironment and therapeutic response in hepatocellular carcinoma.
    Tang B; Zhang X; Yang X; Wang W; Li R; Liu Y
    Front Immunol; 2022; 13():1013248. PubMed ID: 36466855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
    Wang D; Liu J; Liu S; Li W
    Front Genet; 2020; 11():342. PubMed ID: 32391055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
    Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
    J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q; Xu H; Chen S; Huang W
    Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040
    [No Abstract]   [Full Text] [Related]  

  • 14. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
    Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H
    J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients.
    Lv W; Yao Q
    Dis Markers; 2022; 2022():9428660. PubMed ID: 35069936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a survival model based on autophagy-associated genes for predicting prognosis of hepatocellular carcinoma.
    Yang W; Niu L; Zhao X; Duan L; Li Y; Wang X; Zhang Y; Zhou W; Liu J; Zhao Q; Han Y; Fan D; Hong L
    Am J Transl Res; 2020; 12(10):6705-6722. PubMed ID: 33194067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma.
    Li G; Zhang D; Liang C; Liang C; Wu J
    Front Oncol; 2022; 12():1021775. PubMed ID: 36338707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
    Yang Z; Zi Q; Xu K; Wang C; Chi Q
    Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-related gene signature to predict TACE refractoriness in patients with hepatocellular carcinoma based on artificial neural network.
    Xu Q; Wang C; Yin G
    Front Genet; 2022; 13():993509. PubMed ID: 36685822
    [No Abstract]   [Full Text] [Related]  

  • 20. An immune infiltration-related long non-coding RNAs signature predicts prognosis for hepatocellular carcinoma.
    Li G; Xu S; Yang S; Wu C; Zhang L; Wang H
    Front Genet; 2022; 13():1029576. PubMed ID: 36568382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.